Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine- induced Parkinson's disease in rats

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 83-88

  Han, Bing ^a   Hu, Jia ^b   Shen, Jingyu ^a   Gao, Yonglin ^a   Lu, Yan ^a   Wang, Tian ^a  

^a YANTAI UNIVERSITY   (China)

^b YANTAISHAN HOSPITAL   (China)

Author keywords

Brain derived neurotrophic factor; Glial cell line derived neurotrophic factor; Hydroxysafflor yellow A; Parkinson's disease

Indexed keywords

APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYDROXYSAFFLOR YELLOW A; NEUROPROTECTIVE AGENT; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HYDROXYSAFFLOR YELLOW A; PARKINSON'S DISEASE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CHALCONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMOVANILLIC ACID; MALE; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE; QUINONES; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84879832373     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.011     Document Type: Article

References (25)

1. Altar, C.A., Boylan, C.B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S.J., Lindsay, R.M., Hyman, C., 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Nat. Acad. Sci. USA 89, 11347-11351.
2. Benn, S.C., Woolf, C.J., 2004. Adult neuron survival strategies-slamming on the brakes. Nat. Rev. Neurosci. 5, 686-700. (Pubitemid 39150140)
3. Bjorklund, A., 1991. Neural transplantation - an experimental tool with clinical possibilities. Trends Neurosci. 14, 319-322.
4. Blandini, F., Armentero, M.T., Martignoni, E., 2008. The 6-hydroxydopamine model: news from the past. Parkinsonism Relat. Disord. 14 (Suppl 2), S124-129.
5. Chen, L.W., Wang, Y.Q., Wei, L.C., Shi, M., Chan, Y.S., 2007. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol. Disord. Drug Targets 6, 273-281. (Pubitemid 47232939)
6. Duty, S., Jenner, P., 2011. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br. J. Pharmacol. 164, 1357-1391.
7. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J., Gerhardt, G.A., 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255. (Pubitemid 26090648)
8. Han, B., Zhao, H., 2010. Effects of hydroxysafflor yellow A in the attenuation of MPTP neurotoxicity in mice. Neurochem. Res. 35, 107-113.
9. Hyman, C., Hofer, M., Barde, Y.A., Juhasz, M., Yancopoulos, G.D., Squinto, S.P., Lindsay, R.M., 1991. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232. (Pubitemid 21912205)
10. Javoy, F., Sotelo, C., Herbet, A., Agid, Y., 1976. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system. Brain Res. 102, 201-215.
11. Levivier, M., Przedborski, S., Bencsics, C., Kang, U.J., 1995. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15, 7810-7820. (Pubitemid 26006890)
12. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
13. Mo, J., Zhang, H., Yu, L.P., Sun, P.H., Jin, G.Z., Zhen, X., 2008. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol. Aging 31, 926-936.
14. Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., Kunugi, H., 2010. BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25, 237-258.
15. Slevin, J.T., Gerhardt, G.A., Smith, C.D., Gash, D.M., Kryscio, R., Young, B., 2005. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neuro-trophic factor. J. Neurosurg. 102, 216-222. (Pubitemid 43194069)
16. Soderstrom, K., O'Malley, J., Steece-Collier, K., Kordower, J.H., 2006. Neural repair strategies for Parkinson's disease: insights from primate models. Cell Transplant. 15, 251-265. (Pubitemid 43726184)
17. Surmann, A., Havemann-Reinecke, U., 1995. Injection of apomorphine - a test to predict individual different dopaminergic sensitivity? J. Neural Transm. (Suppl. 45), 143-155.
18. Ungerstedt, U., 1971. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. (Suppl. 367), 49-68.
19. Ungerstedt, U., Arbuthnott, G.W., 1970. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
20. Wang, C., Zhang, D., Li, G., Liu, J., Tian, J., Fu, F., Liu, K., 2007. Neuroprotective effects of safflor yellow B on brain ischemic injury. Exp. Brain Res. 177, 533-539. (Pubitemid 46339606)
21. Wei, X., Liu, H., Sun, X., Fu, F., Zhang, X., Wang, J., An, J., Ding, H., 2005. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci. Lett. 386, 58-62. (Pubitemid 41019643)
22. Zhang, K., Tarazi, F.I., Davids, E., Baldessarini, R.J., 2002. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology 26, 625-633. (Pubitemid 34260981)
23. Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R.M., Johansson, C.B., Brismar, H., Shupliakov, O., Frisen, J., Janson, A.M., 2003. Evidence for neuro-genesis in the adult mammalian substantia nigra. Proc. Nat. Acad. Sci. USA 100, 7925-7930. (Pubitemid 36760071)
24. Zhao, X.E., Suo, Y.R., 2008. Simultaneous determination of monoamine and amino acid neurotransmitters in rat endbrain tissues by pre-column derivatization with high-performance liquid chromatographic fluorescence detection and mass spectrometric identification. Talanta 76, 690-697.
25. Zhu, H., Wang, Z., Ma, C., Tian, J., Fu, F., Li, C., Guo, D., Roeder, E., Liu, K., 2003. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta Med. 69, 429-433. (Pubitemid 36774183)